Table 3 Comparisons of clinical indicators before NAC.NICB between the patients achieved pCR and the non-pCR groups.
pCR (N = 14) | Non-pCR (N = 15) | P value | |
|---|---|---|---|
Clinical stage | > 0.999c | ||
=T2N0M0 | 3(21.4%) | 4(26.7%) | |
> T2N0M0 | 11(78.6%) | 11(73.3%) | |
RBC (*10^12/L)† | 4.06 ± 0.76 | 4.56 ± 0.77 | 0.087a |
Hb (g/L)†† | 132.5(117.0-151.3) | 115.0(109.0-127.0) | 0.018*b |
Platelet (*10^9/L)†† | 187.0(148.0-208.3) | 243.0(188.0-333.0) | 0.026*b |
Neutrophil (*10^9/L)†† | 3.95(3.73–4.28) | 3.82(3.27–6.21) | 0.983b |
Lymphocyte (*10^9/L)† | 1.31 ± 0.60 | 1.51 ± 0.58 | 0.383a |
NLR (%)†† | 3.25(2.22–5.46) | 3.02(2.13–4.24) | 0.652b |
PLR (%)† | 179.40 ± 87.63 | 184.24 ± 86.51 | 0.882a |
Albumin (g/L)† | 39.54 ± 4.81 | 40.69 ± 4.53 | 0.531a |
ALG (%)† | 1.33 ± 0.29 | 1.28 ± 0.15 | 0.577a |
